RBC Capital Downgrades BioCryst Pharma (BCRX) to Sector Perform

September 10, 2026 5:11 AM

RBC Capital analyst Brian Abraham downgraded BioCryst Pharma (NASDAQ: BCRX) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found